Tag: cholangiocarcinoma
Results of single-centre study of Chemosat hepatic delivery system published in...
Delcath Systems announced the publication of a retrospective analysis of patients who underwent a percutaneous hepatic perfusion procedure (PHP) with Chemosat for the treatment...
The role of Y-90 radioembolization for cholangiocarcinoma
Y-90 radioembolization is a promising locoregional therapy for a devastating disease with few available treatment options. Ongoing and future clinical trials will help to...
New ESMO biliary cancer guidelines indicate radioembolization as an option for...
New European Society of Medical Oncology (ESMO) biliary cancer guidelines indicate yttrium-90 (Y-90) therapy as an option for post-chemotherapy treatment of intrahepatic cholangiocarcinoma.
Sirtex has announced...
